Page last updated: 2024-11-02

pindolol and Experimental Hepatoma

pindolol has been researched along with Experimental Hepatoma in 3 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, YF1
Harden, TK1
Perkins, JP1
Sanae, F2
Miyamoto, K2
Koshiura, R2

Other Studies

3 other studies available for pindolol and Experimental Hepatoma

ArticleYear
Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process.
    The Journal of biological chemistry, 1980, Aug-10, Volume: 255, Issue:15

    Topics: Adenylyl Cyclases; Animals; Astrocytoma; Catecholamines; Cell Membrane; Enzyme Activation; Epinephri

1980
Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Cancer research, 1989, Nov-15, Volume: 49, Issue:22

    Topics: Adenylyl Cyclases; Albuterol; Animals; Cell Line; Clonidine; Enzyme Activation; Epinephrine; Iodocya

1989
A comparison of adrenergic receptors of rat ascites hepatoma AH130 cells with those of normal rat hepatocytes.
    Cancer letters, 1988, Volume: 39, Issue:3

    Topics: Animals; Clonidine; Female; Iodocyanopindolol; Liver; Liver Neoplasms, Experimental; Pindolol; Prazo

1988